Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-02563-0001-0000-9 |
Chemical Name: | N-Nitrosomorpholine |
CASRN: | 59-89-2 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 579986_SCE |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Test Failure |
No Activation | 2 | Negative |
Induced Rat Liver S9 | 1_S9 | Questionable |
Induced Rat Liver S9 | 2_S9 | Positive |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1046 | 483 | 0.462 | 9.66 | 25.8 | 0.000 |
Test Chemical | N-Nitrosomorpholine | 500.3 | 50 | 1032 | 425 | 0.412 | 8.50 | 25.8 | -10.815 |
1670 | 50 | 1039 | 488 | 0.470 | 9.76 | 25.8 | 1.716 | ||
5000 | 50 | 1037 | 542 | 0.523 | 10.84 | 25.8 | 13.189 | ||
Positive Control | Mitomycin-C | 0.001 | 50 | 1037 | 538 | 0.519 | 10.76 | 25.8 | 12.354 |
Mitomycin-C | 0.01 | 5 | 105 | 193 | 1.838 | 38.60 | 25.8 | 298.064 | |
Trend: | 2.521 | ||||||||
Probability: | 0.006 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1049 | 411 | 0.392 | 8.22 | 25.6 | 0.000 |
Test Chemical | N-Nitrosomorpholine | 500 | 50 | 1047 | 362 | 0.346 | 7.24 | 25.6 | -11.754 |
1670 | 50 | 1048 | 421 | 0.402 | 8.42 | 25.6 | 2.531 | ||
5000 | 50 | 1047 | 438 | 0.418 | 8.76 | 30.8 | 6.773 | ||
Positive Control | Mitomycin-C | 0.001 | 50 | 1047 | 688 | 0.657 | 13.76 | 25.6 | 67.716 |
Mitomycin-C | 0.01 | 5 | 104 | 258 | 2.481 | 51.60 | 25.6 | 533.170 | |
Trend: | 1.577 | ||||||||
Probability: | 0.057 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1036 | 497 | 0.480 | 9.94 | 25.8 | 0.000 |
Test Chemical | N-Nitrosomorpholine | 500.3 | 50 | 1047 | 564 | 0.539 | 11.28 | 25.8 | 12.289 |
1670 | 50 | 1040 | 554 | 0.533 | 11.08 | 25.8 | 11.040 | ||
5000 | 50 | 1045 | 596 | 0.570 | 11.92 | 25.8 | 18.887 | ||
Positive Control | Cyclophosphamide | 0.4 | 50 | 1041 | 690 | 0.663 | 13.80 | 25.8 | 38.166 |
Cyclophosphamide | 2 | 5 | 106 | 210 | 1.981 | 42.00 | 25.8 | 312.968 | |
Trend: | 2.620 | ||||||||
Probability: | 0.004 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 25 | 525 | 223 | 0.425 | 8.92 | 25.5 | 0.000 |
Test Chemical | N-Nitrosomorpholine | 2500 | 25 | 526 | 327 | 0.622 | 13.08 | 25.5 | 46.358 |
3750 | 25 | 524 | 347 | 0.662 | 13.88 | 25.5 | 55.902 | ||
5000 | 25 | 522 | 307 | 0.588 | 12.28 | 25.5 | 38.459 | ||
Positive Control | Cyclophosphamide | 0.4 | 25 | 514 | 332 | 0.646 | 13.28 | 25.5 | 52.065 |
Cyclophosphamide | 2 | 5 | 105 | 149 | 1.419 | 29.80 | 25.5 | 234.081 | |
Trend: | 3.720 | ||||||||
Probability: | 0.000 |